Coloplast A/S Reported In-line with Estimates

Coloplast A/S (CLPBY) reported earnings of $0.10 per share on revenue of $1.14 billion for the fiscal third quarter ended June 2026. The consensus earnings estimate was $0.10 per share. The company reported in-line with consensus estimates while revenue grew 8.13% on a year-over-year basis.

Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark.